INVO Fertility (IVF) Total Non-Current Liabilities (2021 - 2026)
INVO Fertility's (IVF) quarterly Total Non-Current Liabilities came in at $9.3 million in Q1 2026, down 57.44% year-on-year from $21.9 million in Q1 2025, and down 26.49% on a QoQ basis from $12.7 million in Q4 2025.
INVO Fertility (IVF) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends
INVO Fertility (IVF) has 6 years of Total Non-Current Liabilities data on file, last reported at $9.3 million in Q1 2026.
- On a quarterly basis, Total Non-Current Liabilities fell 57.44% year-over-year to $9.3 million in Q1 2026; TTM through Mar 2026 was $9.3 million, a 57.44% decrease from a year earlier, with the FY2025 full-year figure at $12.7 million, down 40.24% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $9.3 million, down from $12.7 million in the prior quarter.
- Over the last five years, Total Non-Current Liabilities for IVF reached as high as $21.9 million in Q1 2025 and fell as low as $107374.0 in Q4 2022.
- Historically, Total Non-Current Liabilities has averaged $5.5 million across 5 years, with a median of $144267.0 in 2022.
- Across the five-year window, Total Non-Current Liabilities surged 17720.43% in 2025 and tumbled 57.44% in 2026, its largest moves.
- Year by year, Total Non-Current Liabilities stood at $107374.0 in 2022, then advanced by 14.61% to $123060.0 in 2023, then surged by 17163.7% to $21.2 million in 2024, then tumbled by 40.24% to $12.7 million in 2025, then declined by 26.49% to $9.3 million in 2026.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $9.3 million in Q1 2026, $12.7 million in Q4 2025, and $12.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | INVO Fertility | 1,108.74 | -4.90 Mn | 732,978.00 | 9.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.33 Mn |
| Dec 31, 2025 | 12.70 Mn |
| Sep 30, 2025 | 12.18 Mn |
| Jun 30, 2025 | 15.56 Mn |
| Mar 31, 2025 | 21.93 Mn |
| Dec 31, 2024 | 21.24 Mn |
| Sep 30, 2024 | 123,060.00 |
| Jun 30, 2024 | 123,060.00 |
| Mar 31, 2024 | 123,060.00 |
| Dec 31, 2023 | 123,060.00 |
| Sep 30, 2023 | 117,989.00 |
| Jun 30, 2023 | 121,773.00 |
| Mar 31, 2023 | 114,824.00 |
| Dec 31, 2022 | 107,374.00 |
| Sep 30, 2022 | 144,267.00 |
| Jun 30, 2022 | 146,585.00 |
| Mar 31, 2022 | 146,515.00 |
| Dec 31, 2021 | 142,321.00 |